Material Agreements

Scorpius Holdings, Inc. entered into Third Note with the Holder valued at $27,109.10 (effective 2026-03-11).

“On March 11, 2026, the Company issued a non-convertible promissory note (the “Third Note”) in the principal amount of Twenty-seven Thousand One Hundred and Nine Dollars and Ten cents ($27,109.10) to the Holder.”

Scorpius Holdings, Inc. entered into Second Note with the Holder valued at $190,907.77 (effective 2026-02-26).

“On February 26, 2026, the Company issued a non-convertible promissory note (the “Second Note”) in the principal amount of One Hundred and Ninety Thousand Nine Hundred and Seven Dollars and Seventy-seven cents ($190,907.77) to the Holder.”

Scorpius Holdings, Inc. entered into First Note with an institutional investor valued at $30,426.95 (effective 2026-02-12).

“On February 12, 2026, Scorpius Holdings, Inc. (the “Company”) issued a non-convertible promissory note (the “First Note”) in the principal amount of Thirty Thousand and Four Hundred and Twenty-six Dollars and ninty-five cents ($30,426.95) to an institutional investor (the “Holder”).”

Horizon Technology Finance Corp entered into LLC Agreement with CR Financial Holdings, Inc. valued at up to $100,000,000.00 (effective 2026-03-18).

“On March 18, 2026, Horizon Technology Finance Corporation (the “Company”), and CR Financial Holdings, Inc. (“CRFH”) entered into a limited liability company agreement (the “LLC Agreement”) to co-manage a newly-formed joint venture, HRZN CRFH LLC (the “Joint Venture”).”

VERDE RESOURCES, INC. entered into Biochar Solutions Supply Agreement with Biochar Solutions LLC valued at BSL will initially supply up to 38,500 U.S. tons of biochar annually; Verde will pay BSL on a per-to (effective 2026-03-14).

“On March 14, 2026, Verde Renewables Inc. (“ Verde ”), a wholly owned subsidiary of Verde Resources, Inc. (the “ Company ”), entered into a Supply Agreement (the “ Agreement ”) with Biochar Solutions LLC (“ BSL ”), pursuant to which BSL will manufacture, supply, distribute, and white label engineered biochar for incorporation into Verde’s and its customers’ products, with both parties intending for this Supply Agreement to serve as the foundation of a binding commercial agreement governing long term biochar supply, carbon credit revenue sharing, joint technology development, and related commercialization activities.”

VINCE HOLDING CORP. amended Second Amendment with Bank of America, N.A. (effective 2026-03-18).

“On March 18, 2026, V Opco, LLC ("Borrower"), an indirectly wholly owned subsidiary of Vince Holding Corp. (the "Company") entered into that certain Second Amendment (the "Second Amendment") to that certain Credit Agreement, dated June 23, 2023, by and among the Borrower, the guarantors named therein, Bank of America, N.A., as Agent, the other lenders from time to time party thereto, and BoA Securities, Inc., as sole lead arranger and sole bookowner (the "ABL Credit Agreement")”

SmartStop Self Storage REIT, Inc. entered into Agreement with J.P. Morgan Securities, LLC, BMO Capital Markets Corp., Evercore Group L.L.C., Huntington Securities, Inc., KeyBanc Capital Markets Inc., M&T Securities, Inc., Raymond James & Associates, Inc., RBC Capital Markets, LLC, Robert W. Baird & Co. Incorporated, Scotia Capital (USA) Inc., Truist Securities valued at up to $300 million (effective 2026-03-19).

“On March 19, 2026, SmartStop Self Storage REIT, Inc., a Maryland corporation (the “Company”) and SmartStop OP, L.P., a Delaware limited partnership (“the “Operating Partnership” and, together with the Company, “SmartStop”), entered into a distribution agreement (the “Agreement”) with each of J.P. Morgan Securities, LLC, BMO Capital Markets Corp., Evercore Group L.L.C., Huntington Securities, Inc., KeyBanc Capital Markets Inc., M&T Securities, Inc., Raymond James & Associates, Inc., RBC Capital Markets, LLC, Robert W. Baird & Co. Incorporated, Scotia Capital (USA) Inc., Truist Securities, Inc., and Wells Fargo Securities, LLC, as sales agents (in such capacity, “Sales Agents”), the Forward Sellers (as defined below and together with the Sales Agents, the “Agents”) and the Forward Purchasers (as defined below). Pursuant to the Agreement, the Company may issue and sell, from time to time, shares of its common stock, par value $0.001 per share (the “Common Stock”) having an aggregate offer”

Evofem Biosciences, Inc. terminated Termination Agreement with Windtree Therapeutics, Inc. (effective 2026-03-13).

“the Company and Windtree entered into a Termination Agreement (the “Termination Agreement”) pursuant to which the parties mutually consented to the termination of the Agreement, effective as of such date.”

Datavault AI Inc. entered into Agreement and Plan of Merger with NYIAX, Inc. valued at 78,947,368 shares of the Company’s common stock (effective 2026-03-18).

“Datavault AI Inc., (the “Company”), DVLT Merger Sub, Inc., a wholly owned subsidiary of the Company (“Merger Sub”), and NYIAX, Inc. (“NYIAX”) entered into an Agreement and Plan of Merger (the “Merger Agreement”), dated March 18, 2026.”

IMAC Holdings, Inc. entered into Securities Purchase Agreement with Aditxt, Inc. ("ADTX") and several investors party thereto valued at aggregate of $36,000,000 (effective 2026-03-11).

“On March 11, 2026, the Company also entered into a securities purchase agreement (the “Securities Purchase Agreement”) with ADTX and several investors party thereto (the “Investors”) pursuant to which ADTX sold a new series of convertible preferred stock designated as Series A-2 convertible preferred stock, $0.001 par value per share which are convertible to shares of common stock (the “A-2 Preferred Stock”) in an amount of $1,000 per share (for an aggregate of $36,000,000).”

IMAC Holdings, Inc. entered into Turnover and Release Agreement with Cavalry Fund I SPV I LP (as collateral agent) and the Noteholders valued at stated value of at least $35 million (effective 2026-03-11).

“On March 11, 2026, IMAC Holdings, Inc., a Delaware corporation (the “Company”) entered into a voluntary turnover, retention in satisfaction and release agreement (the “Turnover and Release Agreement”) with Cavalry Fund I SPV I LP, a Delaware limited partnership, as collateral agent (the “Collateral Agent”) and the holders (the “Noteholders”) of senior secured notes”

BiomX Inc. amended Warrant Amendment with the Investor (effective 2026-03-13).

“On March 13, 2026, the Company and the Investor entered into an amendment to the Warrant (the “Warrant Amendment”), pursuant to which, the Investor and the Company agreed to (i) amend the term of the Warrant, such that the Warrant will expire on December 31, 2026, (ii) reduce the exercise price of the Warrant from $2.00 to $1.00 per share, and (iii) revise the method of determining the number of shares of Common Stock issuable upon a cashless exercise of the Warrant such that the number of shares of Common Stock issuable upon cashless exercise will be determined by reference, where applicable, to the lowest VWAP on the five (5) trading days immediately preceding the date on which the notice of exercise is submitted to the Company, rather than the VWAP on the day immediately preceding the date on which the notice of exercise is submitted.”

Monroe Capital Income Plus Corp amended First Amendment to Loan, Security and Servicing Agreement with MC Income Plus Financing SPV V LLC, Capital One, National Association valued at $400,000,000 of aggregate commitments (effective 2026-03-17).

“On March 17, 2026, the Company entered into the First Amendment to Loan, Security and Servicing Agreement ("First Amendment"), by and among MC Income Plus Financing SPV V LLC, a wholly-owned subsidiary of the Company, as borrower, the Company, as servicer, the lenders party thereto, Capital One, National Association, as administrative agent, U.S. Bank Trust Company, National Association, as collateral custodian and as collateral administrator, and U.S. Bank National Association, as document custodian.”

Monroe Capital Income Plus Corp amended Second Amendment to Loan, Security and Servicing Agreement with MC Income Plus Financing SPV IV LLC, Capital One, National Association valued at $400,000,000 of aggregate commitments (effective 2026-03-17).

“On March 17, 2026, Monroe Capital Income Plus Corporation (the "Company") entered into the Second Amendment to Loan, Security and Servicing Agreement ("Second Amendment"), by and among MC Income Plus Financing SPV IV LLC, a wholly-owned subsidiary of the Company, as borrower, the Company, as servicer, the lenders party thereto, Capital One, National Association, as administrative agent, U.S. Bank Trust Company, National Association, as collateral custodian and as collateral administrator, and U.S. Bank National Association, as document custodian.”

REVIVA PHARMACEUTICALS HOLDINGS, INC. entered into Placement Agency Agreement with A.G.P./Alliance Global Partners valued at 7.0% of the aggregate gross proceeds (effective 2026-03-18).

“the Company entered into a placement agency agreement (the “Placement Agency Agreement”), dated March 18, 2026, with A.G.P./Alliance Global Partners (the “Placement Agent”) pursuant to which the Company agreed to pay the Placement Agent a total cash fee equal to 7.0% of the aggregate gross proceeds of the Offering”

REVIVA PHARMACEUTICALS HOLDINGS, INC. entered into Purchase Agreement with certain institutional investors valued at $10.0 million (effective 2026-03-18).

“On March 18, 2026, Reviva Pharmaceuticals Holdings, Inc. (the “Company”) entered into agreements, including a securities purchase agreement (the “Purchase Agreement”) with certain institutional investors, pursuant to which the Company agreed to sell and issue, in a registered public offering (the “Offering”), (i) an aggregate of 6,283,334 shares (the “Shares”) of the Company’s common stock”

SmartKem, Inc. entered into Intellectual Property Assignment Agreement with Smartkem Ltd (Assignor) and Smartkem IP LLC (Assignee) (effective 2026-03-18).

“In furtherance thereof, the Company and its subsidiary, Smartkem Ltd, a corporation organized under English law (the "Assignor"), entered into an Intellectual Property Assignment Agreement (the "IP Assignment Agreement") with Smartkem IP LLC (the "Assignee"), pursuant to which the Assignor irrevocably conveyed, transferred, and assigned to the Assignee certain of the Assignor's right, title, and interest in and to certain patents, patent applications, and related intellectual property rights, together with all royalties, fees, income, and proceeds related thereto, and all claims and causes of action with respect thereto.”

SmartKem, Inc. entered into Waiver and Termination Agreements with the Holders (effective 2026-03-18).

“In connection with the Settlement Agreements, the Company and the Holders entered into Waiver and Termination Agreements (the "Waiver and Termination Agreements") with respect to the Prior Purchase Agreement.”

SmartKem, Inc. entered into Settlement Agreements with certain holders (collectively, the 'Holders') of those certain Senior Secured Notes valued at $300,000 (effective 2026-03-18).

“Pursuant to the Settlement Agreements, the Company agreed to (i) repay each Holder the outstanding principal amount of its respective Prior Note in full within two (2) business days following the effective date of the Settlement Agreements, and (ii) pay to the Holders an aggregate cash settlement payment of $300,000 by wire transfer of immediately available funds.”

SmartKem, Inc. entered into Securities Purchase Agreement with certain accredited investors valued at $3,750,000 (effective 2026-03-18).

“On March 18, 2026, SmartKem, Inc. (the “Company”) entered into a Securities Purchase Agreement (the "Purchase Agreement") with certain accredited investors (the "Buyers"), pursuant to which the Company agreed to issue and sell to the Buyers senior secured promissory notes (the "Notes") in the aggregate original principal amount of $3,750,000 for an aggregate purchase price of $2,625,000, reflecting an original issue discount of approximately 30%.”

Humacyte, Inc. entered into Placement Agreement with Titan Partners Group LLC, a division of American Capital Partners, LLC (effective 2026-03-19).

“On March 19, 2026, the Company also entered into a placement agent agreement (the “Placement Agreement”) with Titan Partners Group LLC, a division of American Capital Partners, LLC, as the placement agent (the “Placement Agent”), in connection with the Offering.”

Humacyte, Inc. entered into Purchase Agreements with certain investors valued at 25,000,000 shares ... at a price of $0.80 per share (effective 2026-03-19).

“On March 19, 2026, Humacyte, Inc. (the “Company”) entered into certain securities purchase agreements (the “Purchase Agreements”) pursuant to which the Company agreed to issue and sell to certain investors in a registered direct offering (the “Offering”) 25,000,000 shares of the Company’s common stock, $0.0001 par value per share, at a price of $0.80 per share (the “Shares”).”

SAB Biotherapeutics, Inc. entered into Underwriting Agreement with Jefferies LLC, UBS Securities LLC, Citigroup Capital Markets, Inc. and Barclays Capital Inc. valued at underwritten offering of common stock and pre-funded warrants (effective 2026-03-17).

“On March 17, 2026, SAB Biotherapeutics, Inc. (the “Company” or “SAB”) entered into an underwriting agreement (the “Underwriting Agreement”) with Jefferies LLC, UBS Securities LLC, Citigroup Capital Markets, Inc. and Barclays Capital Inc. (collectively, the “Representatives”) as the representatives of the several underwriters named therein (the “Underwriters”), relating to an underwritten offering (the “Offering”) of (i) 19,324,677 shares (the “Firm Shares”) of the Company’s common stock, $0.0001 par value per share (the “Common Stock”), at a price to the public of $3.85 per Firm Share, and (ii) pre-funded warrants to purchase up to 2,753,246 shares of Common Stock (the “Pre-Funded Warrants”), and such shares issuable upon the exercise of the Pre-Funded Warrants (the “Warrant Shares”), at a price to the public of $3.8499 per Pre-Funded Warrant, which represents the per share public offering price for the Firm Shares less the $0.0001 per share exercise price for each such Pre-Funded Warr”

Constellation Acquisition Corp I amended Second Amendment with Constellation Sponsor LP valued at $3,000,000 (effective 2026-03-18).

“On March 18, 2026, the Company further amended the Promissory Note (the “Second Amendment”), to increase the principal amount by $3,000,000 from $2,250,000 to $5,250,000.”

Pyrophyte Acquisition Corp. amended Amendment No. 5 with Sio Silica Corporation, Snowbank NewCo Alberta ULC, Sio Silica Incorporated (effective 2026-03-13).

“On March 13, 2026, Pyrophyte Acquisition Corp., a Cayman Islands exempted company (“ Pyrophyte ”), entered into an amendment “ Amendment No. 5 ”) to the previously announced business combination agreement, dated November 13, 2023, by and among Pyrophyte, Sio Silica Corporation, an Alberta corporation (“ Sio ”), Snowbank NewCo Alberta ULC, an Alberta unlimited liability corporation and a wholly-owned subsidiary of Pyrophyte (“ Pyrophyte Newco ”), and Sio Silica Incorporated, an Alberta corporation (“ Sio Newco ”) (the “ Sio Business Combination Agreement ”), with Sio, Pyrophyte Newco and Sio Newco, pursuant to which the parties agreed to extend the outside date from April 29, 2026 to April 29, 2027.”

Senti Biosciences, Inc. entered into Letter Agreement with GeneFab, LLC valued at outstanding base rent of $1,374,005 may be satisfied via cash prepayment credit for work or services (effective 2025-09-01).

“On March 17, 2026, the Company entered into a letter agreement with GeneFab (the “Letter Agreement”), effective as of the Effective Date. The Letter Agreement provides, among other things, that the outstanding base rent of $1,374,005 owed by GeneFab to the Company may be satisfied, in whole or in part, through a cash prepayment credit to be applied toward work or services to be performed by GeneFab for the Company under a separate arrangement, that the Company may access such prepayment credit as of the Effective Date and that any unpaid portion must be paid in immediately available funds by September 1, 2026.”

Senti Biosciences, Inc. amended First Amendment to Landlord's Consent to Sublease with 1430 South Loop Owner, LLC and GeneFab, LLC valued at Landlord consented to Sublease Amendment in consideration for $1.0 million Reduction Fee (effective 2025-09-01).

“On March 17, 2026, the Company entered into a First Amendment to Landlord’s Consent to Sublease (the “Consent Amendment”) among the Company, the Landlord and GeneFab, which was effective as of the Effective Date. Pursuant to the Consent Amendment, the Landlord consented to the Sublease Amendment in consideration for the payment by the Company or GeneFab of $1.0 million to the Landlord (the “Reduction Fee”).”

Senti Biosciences, Inc. amended First Amendment to Sublease with GeneFab, LLC valued at subleased premises reduced to ~45,955 rentable square feet; base rent, operating expenses, taxes and (effective 2025-09-01).

“On March 17, 2026, the Company entered into a First Amendment to Sublease (the “Sublease Amendment”), which amended and restated that certain Sublease Agreement dated August 7, 2023 (the “Original Sublease Agreement” and the Original Sublease Agreement as amended by the Sublease Amendment, the “Amended Sublease”) by and between the Company, as sublandlord, and GeneFab, LLC (“GeneFab”) as subtenant. Pursuant to the Sublease Amendment, which was effective as of the Effective Date, the subleased premises were reduced to approximately 45,955 rentable square feet as of the Effective Date.”

Senti Biosciences, Inc. amended First Amendment to Lease with 1430 South Loop Owner, LLC valued at reduction of leased premises from ~91,910 to ~45,955 rentable square feet; monthly base rent reduced (effective 2025-09-01).

“On March 17, 2026, Senti Biosciences, Inc. (the “Company”) entered into a First Amendment to Lease (the “Lease Amendment”), which amended that certain Research and Development and Laboratory Lease Agreement dated June 3, 2021 (the “Original Lease Agreement” and the Original Lease Agreement as amended by the Lease Amendment, the “Amended Lease”) by and between the Company and 1430 South Loop Owner, LLC (the “Landlord”) for the Company’s premises located at 1430 Harbor Bay Parkway, Alameda, California. Pursuant to the Lease Amendment, which is effective as of September 1, 2025 (the “Effective Date”), the Company has agreed to a reduction of the leased premises from approximately 91,910 rentable square feet to approximately 45,955 rentable square feet as of the Effective Date.”

Twin Vee PowerCats, Co. entered into Placement Agency Agreement with ThinkEquity LLC valued at aggregate gross proceeds of approximately $1.7 million (effective 2026-03-16).

“On March 16, 2026, Twin Vee PowerCats Co., a Delaware corporation (the “Company”), entered into a placement agency agreement (the “Placement Agency Agreement”) with ThinkEquity LLC, as sole placement agent (the “Placement Agent”), pursuant to which the Company agreed to issue and sell directly to various investors in a best efforts public offering (the “Offering”) an aggregate of 4,473,000 shares (the “Shares”) of the Company’s common stock, par value $0.001 per share (the “Common Stock”), at a public offering price of $0.38 per share.”

Alpha Star Acquisition Corp entered into Loan Agreement with A-Star Management Corp. valued at $500,000 (effective 2026-03-16).

“On March 16, 2026, Alpha Star Acquisition Company (the “Company”) entered into a Loan Agreement (the “Loan Agreement”), by and among the Company and A-Star Management Corp., the Company’s sponsor (the “Sponsor”), pursuant to which the Sponsor agreed to loan an aggregate of US$500,000 to the Company, to cover the Company’s certain transaction costs and extension fee (the “Loan”).”

Rivian Automotive, Inc. / DE entered into Master Framework Agreement with Rivian, LLC and Uber Technologies, Inc. (effective 2026-03-18).

“On the Effective Date, in connection with the execution and delivery of the Subscription Agreement, Rivian, LLC, a Delaware limited liability company and wholly-owned subsidiary of the Company ("Subsidiary"), entered into a Master Framework Agreement (the "Master Framework Agreement") by and among the Subsidiary, the Company and Uber, governing the collaboration between Subsidiary and Uber to develop, deploy, and operate autonomous vehicles on the Uber platform.”

Rivian Automotive, Inc. / DE entered into Subscription Agreement with SMB Holding Corporation and Uber Technologies, Inc. valued at $300 million (effective 2026-03-18).

“On March 18, 2026 (the “Effective Date”), Rivian Automotive, Inc., a Delaware corporation (the “Company”), entered into a subscription agreement (the “Subscription Agreement”) by and among the Company, SMB Holding Corporation (“SMB”) and Uber Technologies, Inc. (“Uber”), providing for SMB’s investment in the Company through the sale and issuance of shares of the Company’s Class A common stock”

KKR FS Income Trust amended Second Amendment to Senior Secured Revolving Credit Agreement with Sumitomo Mitsui Banking Corporation, as administrative agent and collateral agent valued at from $520 million to $570 million (effective 2026-03-17).

“On March 17, 2026, KKR FS Income Trust (the “Company”), together with the subsidiary guarantors party thereto, entered into a Second Amendment to Senior Secured Revolving Credit Agreement (the “Second Amendment”) to the Senior Secured Revolving Credit Agreement, dated as of July 19, 2023 (as previously amended by that certain First Amendment to Senior Secured Revolving Credit Agreement, dated as of January 26, 2024, the “Credit Agreement”), by and among the Company, as borrower, the subsidiary guarantors party thereto, the lenders and issuing banks from time to time party thereto, and Sumitomo Mitsui Banking Corporation, as administrative agent and collateral agent.”

LITHIUM AMERICAS CORP. entered into Equity Distribution Agreement with TD Securities (USA) LLC valued at up to US$250,000,000 (effective 2026-03-19).

“On March 19, 2026, Lithium Americas Corp., a company incorporated under the laws of British Columbia, Canada (the “ Company ”), entered into an Equity Distribution Agreement (the “ Agreement ”) with TD Securities (USA) LLC (the “ Agent ”), as sales agent and/or principal, pursuant to which the Company may offer and sell, from time to time, through the Agent, its common shares, without par value (the “ Common Shares ”), having an aggregate offering price of up to US$250,000,000 (the “ ATM Program ”).”

Ares Core Infrastructure Fund amended Aspen Facility Amendment with MUFG Bank, LTD (as Administrative Agent) and BNP Paribas (as Collateral Agent) valued at $249.90 million (effective 2026-03-13).

“On March 13, 2026 (the “Amendment Effective Date”), Ares Aspen Member LLC as borrower (the “Borrower”) and Ares Aspen Holdings LLC as pledgor (the “Pledgor”), each a wholly-owned subsidiary of Ares Core Infrastructure Fund (the “Fund”), entered into the First Amendment to Credit Agreement and First Amendment to Pledge and Security Agreement (the “Aspen Facility Amendment”)”

Mount Logan Capital Inc. entered into Transition Services Agreement with Willow Asset Management LLC valued at up to $5,000,000 (effective 2026-03-18).

“On March 18, 2026, Mount Logan Management, LLC (“ MLM ”), a Delaware limited liability company and wholly owned indirect subsidiary of Mount Logan Capital Inc. (the “ Company ”), entered into a Transition Services Agreement (“ TSA ”) with Willow Asset Management LLC (“ Willow ”).”

Blue Acquisition Corp/Cayman amended First Amendment to the Business Combination Agreement with Blockfusion Data Centers, Inc. valued at Amendment to increase post-Closing incentive plan to 8% and board size to nine members (effective 2026-03-19).

“On March 19, 2026, Blue, Blockfusion, and Pubco entered into the First Amendment to the BCA (the “ First Amendment ”) to amend the BCA to: (i) increase the post-Closing incentive plan from five percent (5%) of the aggregate number of shares of Pubco Common Stock (as defined in the BCA) issued and outstanding immediately after the Closing to eight percent (8%) of the aggregate number of shares of Pubco Common Stock issued and outstanding immediately after the Closing, and (ii) increase the size of the Post-Closing Pubco Board from seven (7) members to nine (9) members.”

DAYTON POWER & LIGHT CO entered into First Amendment to the Credit Agreement with PNC Bank, National Association valued at Amendment to Third Amended and Restated Credit Agreement dated March 25, 2025 (effective 2026-03-13).

“On March 13, 2026, following the announcement on March 2, 2026 that The AES Corporation (“AES”) had entered into an Agreement and Plan of Merger, by and among AES, Horizon Parent, L.P., a Delaware limited partnership (“Parent”), and Horizon Merger Sub, Inc., a Delaware corporation and wholly owned subsidiary of Parent, The Dayton Power and Light Company (d/b/a AES Ohio) (the “Company”) entered into a First Amendment to the Credit Agreement (the “PNC First Amendment”), by and among the Company, the lenders party thereto and PNC Bank, National Association, as administrative agent, which amends that certain Third Amended and Restated Credit Agreement, dated as of March 25, 2025 (the “PNC Credit Agreement”), by and among the Company, as borrower, the lenders from time to time party thereto and PNC Bank, National Association, as administrative agent.”

ALLIANT ENERGY CORP entered into Distribution Agreement with Barclays Capital Inc., BofA Securities, Inc., Goldman Sachs & Co. LLC, J.P. Morgan Securities LLC, KeyBanc Capital Markets Inc., Mizuho Securities USA LLC, MUFG Securities Americas Inc., TD Securities (USA) LLC, and Wells Fargo Securities, LLC, as agents, and Barclays Bank PLC, Bank of America, N.A. valued at up to $1,000,000,000 (effective 2026-03-19).

“On March 19, 2026, Alliant Energy Corporation (the “Company”), entered into a distribution agreement (the “Distribution Agreement”) with Barclays Capital Inc., BofA Securities, Inc., Goldman Sachs & Co. LLC, J.P. Morgan Securities LLC, KeyBanc Capital Markets Inc., Mizuho Securities USA LLC, MUFG Securities Americas Inc., TD Securities (USA) LLC, and Wells Fargo Securities, LLC, as agents (the “Agents” and each, an “Agent”), and Barclays Bank PLC, Bank of America, N.A., Goldman Sachs & Co. LLC, JPMorgan Chase Bank, National Association, KeyBanc Capital Markets Inc., Mizuho Markets Americas LLC, MUFG Securities EMEA plc, The Toronto-Dominion Bank and Wells Fargo Bank, National Association, as forward purchasers”

Cheniere Energy, Inc. entered into Registration Rights Agreement with Goldman Sachs & Co. LLC, as representative of the initial purchasers (effective 2026-03-19).

“Cheniere and Goldman Sachs & Co. LLC, as representative of the initial purchasers, entered into a Registration Rights Agreement dated as of the Issue Date (the “Registration Rights Agreement”).”

Cheniere Energy, Inc. entered into Second Supplemental Indenture (effective 2026-03-19).

“the second supplemental indenture, dated as of the Issue Date, between Cheniere and the Trustee, relating to the 2056 Notes (the “Second Supplemental Indenture”)”

Cheniere Energy, Inc. entered into First Supplemental Indenture (effective 2026-03-19).

“the first supplemental indenture, dated as of the Issue Date, between Cheniere and the Trustee, relating to the 2036 Notes (the “First Supplemental Indenture”)”

Cheniere Energy, Inc. entered into Base Indenture with The Bank of New York Mellon, as trustee (effective 2026-03-19).

“On March 19, 2026 (the “Issue Date”), Cheniere Energy, Inc. (“Cheniere”) closed the sale of its previously announced offering of $1 billion aggregate principal amount of 5.200% Senior Notes due 2036 (the “2036 Notes”) and $750 million aggregate principal amount of its 6.000% Senior Notes due 2056 (the “2056 Notes” and, together with the 2036 Notes, the “Notes”).”

Forward Industries, Inc. entered into Securities Repurchase Agreement with an institutional investor valued at approximately $27.4 million (effective 2026-03-18).

“On March 18, 2026, Forward Industries, Inc. (the “Company”) entered into a Securities Repurchase Agreement (the “Repurchase Agreement”) with an institutional investor (the “Seller”), pursuant to which the Company repurchased 6,164,324 shares of its common stock (the “Shares”).”

AMERICAN VANGUARD CORP terminated Third Amended and Restated Credit Agreement with Not specified valued at Termination of Prior Credit Agreement, retirement of all outstanding loans using proceeds from Term (effective 2026-03-13).

“On March 13, 2026, AMVAC, as borrower, and certain affiliates (including the Company), as guarantors and/or borrowers, terminated the Prior Credit Agreement concurrently with its entry into the Term Loans (as more fully described in Item 1.01, which is incorporated by reference herein)”

AMERICAN VANGUARD CORP entered into Credit and Guaranty Agreement (First Lien Term Loan) with Centerbridge Partners, L.P. and Wilmington Trust, National Association valued at $225 million senior secured term loan facility (effective 2026-03-13).

“On March 13, 2026, AMVAC Chemical Corporation (“AMVAC”), a subsidiary of American Vanguard Corporation (the “Company”), as borrower, and certain affiliates of the Company (including the Company), as guarantors, entered into (i) a Credit and Guaranty Agreement (the “First Lien Term Loan”) with a group of commercial lenders led by Centerbridge Partners, L.P., and Wilmington Trust, National Association as administrative agent”

AMERICAN SHARED HOSPITAL SERVICES amended Amendment Two to Proton Beam Radiation Therapy Lease Agreement with Orlando Health, Inc. (effective 2026-03-13).

“On March 13, 2026, the Company and Orlando Health entered into Amendment Two to Proton Beam Radiation Therapy Lease Agreement (the “Amendment”).”

AES CORP amended Barclays First Amendment with Barclays Bank PLC valued at Amendment to Letter of Credit Agreement modifying change of control provisions (effective 2026-03-16).

“(iii) Amendment No. 1 to the Letter of Credit Agreement (the “Barclays First Amendment”) on March 16, 2026, by and among the Company and Barclays Bank PLC, as the bank, which amends that certain Letter of Credit Agreement, dated as of December 8, 2025, by and among the Company, as account party, and Barclays Bank PLC, as the bank”

AES CORP amended SMBC First Amendment with Sumitomo Mitsui Banking Corporation valued at Amendment to Credit Agreement modifying change of control provisions (effective 2026-03-16).

“(ii) First Amendment to Credit Agreement (the “SMBC First Amendment”) on March 16, 2026, by and among the Company, the lenders party thereto and Sumitomo Mitsui Banking Corporation, as administrative agent, which amends that certain Credit Agreement, dated as of December 6, 2024, by and among the Company, as borrower, the lenders party thereto and Sumitomo Mitsui Banking Corporation, as administrative agent”